Said N - Search Results

1

Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.

Sharma S, Xing F, Liu Y, Wu K, Said N, Pochampally R, Shiozawa Y, Lin HK, Balaji KC, Watabe K. Sharma S, et al. Among authors: said n. J Biol Chem. 2016 Sep 9;291(37):19351-63. doi: 10.1074/jbc.M116.737379. Epub 2016 Jul 15. J Biol Chem. 2016. PMID: 27422817 Free PMC article.

2

Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.

Said N, Motamed K. Said N, et al. Am J Pathol. 2005 Dec;167(6):1739-52. doi: 10.1016/S0002-9440(10)61255-2. Am J Pathol. 2005. PMID: 16314484 Free PMC article.

3

The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.

Said N, Frierson HF Jr, Chernauskas D, Conaway M, Motamed K, Theodorescu D. Said N, et al. Oncogene. 2009 Oct 1;28(39):3487-98. doi: 10.1038/onc.2009.205. Epub 2009 Jul 13. Oncogene. 2009. PMID: 19597474

4

Roles of SPARC in urothelial carcinogenesis, progression and metastasis.

Said N. Said N. Oncotarget. 2016 Oct 11;7(41):67574-67585. doi: 10.18632/oncotarget.11590. Oncotarget. 2016. PMID: 27564266 Free PMC article. Review.

5

Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.

John B, Naczki C, Patel C, Ghoneum A, Qasem S, Salih Z, Said N. John B, et al. Among authors: said n. Oncogene. 2019 May;38(22):4366-4383. doi: 10.1038/s41388-019-0728-3. Epub 2019 Feb 14. Oncogene. 2019. PMID: 30765860 Free PMC article.

6

Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.

Said N, Najwer I, Motamed K. Said N, et al. Am J Pathol. 2007 Mar;170(3):1054-63. doi: 10.2353/ajpath.2007.060903. Am J Pathol. 2007. PMID: 17322388 Free PMC article.

7

SPARC ameliorates ovarian cancer-associated inflammation.

Said NA, Elmarakby AA, Imig JD, Fulton DJ, Motamed K. Said NA, et al. Neoplasia. 2008 Oct;10(10):1092-104. doi: 10.1593/neo.08672. Neoplasia. 2008. PMID: 18813349 Free PMC article.

8

Aberrant promoter methylation of SPARC in ovarian cancer.

Socha MJ, Said N, Dai Y, Kwong J, Ramalingam P, Trieu V, Desai N, Mok SC, Motamed K. Socha MJ, et al. Among authors: said n. Neoplasia. 2009 Feb;11(2):126-35. doi: 10.1593/neo.81146. Neoplasia. 2009. PMID: 19177197 Free PMC article.

9

Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities.

Ghoneum A, Afify H, Salih Z, Kelly M, Said N. Ghoneum A, et al. Among authors: said n. Cancer Med. 2018 Oct;7(10):5047-5056. doi: 10.1002/cam4.1741. Epub 2018 Aug 21. Cancer Med. 2018. PMID: 30133163 Free PMC article. Review.

10

SPARC Inhibits Metabolic Plasticity in Ovarian Cancer.

Naczki C, John B, Patel C, Lafferty A, Ghoneum A, Afify H, White M, Davis A, Jin G, Kridel S, Said N. Naczki C, et al. Among authors: said n. Cancers (Basel). 2018 Oct 16;10(10):385. doi: 10.3390/cancers10100385. Cancers (Basel). 2018. PMID: 30332737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters